Form 8-K - Current report:
SEC Accession No. 0001558370-21-000289
Filing Date
2021-01-20
Accepted
2021-01-20 08:33:04
Documents
3
Period of Report
2021-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210119x8k.htm 8-K 58738
2 EX-2.1 tmb-20210119xex2d1.htm EX-2.1 681902
3 EX-99.1 tmb-20210119xex99d1.htm EX-99.1 92744
  Complete submission text file 0001558370-21-000289.txt   834530
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 21537456
SIC: 3841 Surgical & Medical Instruments & Apparatus